Home page  | Editorial   | Journal  |  Guidelines to authors |  Contact  | |  
 

Acta Medica Medianae
Vol. 46, No 3, Oktobar, 2007
UDK 61
YU ISSN 0365-4478
 

 

Correspondence to:
Nataša Đorđević

Katedra za farmakologiju i toksikologiju Medicinskog fakulteta

34000 Kragujevac, Srbija

Tel.: 027/324-000

E-mail: natashadj2002@yahoo.com

 

Copyright 2007 by Faculty  of Medicine, University of Nis

PHARMACOGENETICS – THE FUTURE OF THE DRUG THERAPY

 

 Natasa Djordjevic and Slobodan Jankovic

 

 Katedra za farmakologiju i toksikologiju Medicinskog fakulteta u Kragujevcu

 

 

Individual variation in response to drugs is an important clinical problem, which ranges from failure to respond to a drug to adverse drug reactions. Medical therapy still aims at the broadest patient population that might possibly benefit from it, relying on statistical analysis of this population's response for predicting therapeutic outcome. Yet, certain percentage of patients will obtain no benefit from a given drug, or will experience toxicity. Pharmacogenetics, which deals with the genetic basis underlying variable drug response, offers the potential of individualizing drug therapy, and through optimizing efficacy and minimizing toxicity it increases the possibility for a wide range of diseases to be cured and controlled. Acta Medica Medianae 2007;46(2): 56-61.

 

Key words: pharmacogenetics, genetic polymorphism, drug metabolism, drug responce

Full text